Literature DB >> 8688763

What constitutes controlled hypertension? Patient based comparison of hypertension guidelines.

T P Fahey1, T J Peters.   

Abstract

OBJECTIVES: To investigate and quantify the extent to which variations in guidelines influence assessment of control of hypertension.
DESIGN: Cross sectional study. Selected patients had hypertension assessed as controlled or uncontrolled with guidelines from New Zealand, Canada, the United States, Britain, and the World Health Organisation.
SETTING: 18 general practices in Oxfordshire.
SUBJECTS: 876 patients with diagnosed hypertension and taking antihypertensive drugs. MAIN OUTCOME MEASURES: Proportion of patients with controlled hypertension according to each set of guidelines.
RESULTS: The proportion of patients with controlled hypertension varied from 17.5% to 84.6% with the different guidelines after adjustment for the sampling method. All five sets of guidelines agreed on the classification for 31% (277) of the patients. The New Zealand guidelines calculate an absolute risk of a cardiovascular event. When this was taken as the standard half of the patients with uncontrolled hypertension by the United States criteria would be treated unnecessarily and 31% of those classified as having controlled hypertension by the Canadian guidelines would be denied beneficial treatment.
CONCLUSIONS: Hypertension guidelines are inconsistent in their recommendations and need to make clear the absolute benefits and risks of treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8688763      PMCID: PMC2351512          DOI: 10.1136/bmj.313.7049.93

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  22 in total

1.  Risks and benefits of treating mild hypertension: a misleading meta-analysis?

Authors:  M Egger; G D Smith
Journal:  J Hypertens       Date:  1995-07       Impact factor: 4.844

2.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Authors:  B Dahlöf; L H Lindholm; L Hansson; B Scherstén; T Ekbom; P O Wester
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

3.  Guidelines on guidelines.

Authors:  J D Swales
Journal:  J Hypertens       Date:  1993-09       Impact factor: 4.844

4.  Who benefits from medical interventions?

Authors:  G D Smith; M Egger
Journal:  BMJ       Date:  1994-01-08

Review 5.  Pharmacological treatment of hypertension.

Authors:  J D Swales
Journal:  Lancet       Date:  1994-08-06       Impact factor: 79.321

6.  Methods for comparing event rates in intervention studies when the unit of allocation is a cluster.

Authors:  A Donner; N Klar
Journal:  Am J Epidemiol       Date:  1994-08-01       Impact factor: 4.897

7.  Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension.

Authors:  A W Hoes; D E Grobbee; J Lubsen
Journal:  J Hypertens       Date:  1995-07       Impact factor: 4.844

8.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Authors:  P Sever; G Beevers; C Bulpitt; A Lever; L Ramsay; J Reid; J Swales
Journal:  BMJ       Date:  1993-04-10

Review 9.  Blood pressure management: individualized treatment based on absolute risk and the potential for benefit.

Authors:  M H Alderman
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

10.  Management of raised blood pressure in New Zealand: a discussion document.

Authors:  R Jackson; P Barham; J Bills; T Birch; L McLennan; S MacMahon; T Maling
Journal:  BMJ       Date:  1993-07-10
View more
  26 in total

1.  Ageing Britain--challenges and opportunities for general practice.

Authors:  M Drury; J Neuberger
Journal:  Br J Gen Pract       Date:  2001-01       Impact factor: 5.386

2.  What is the quality of drug therapy clinical practice guidelines in Canada?

Authors:  I D Graham; S Beardall; A O Carter; J Glennie; P C Hébert; J M Tetroe; F A McAlister; S Visentin; G M Anderson
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

3.  Blood pressure control in treated hypertensive patients: clinical performance of general practitioners.

Authors:  B D Frijling; T H Spies; C M Lobo; M E Hulscher; B B van Drenth; J C Braspenning; A Prins; J C van der Wouden; R P Grol
Journal:  Br J Gen Pract       Date:  2001-01       Impact factor: 5.386

Review 4.  Developing national outcome standards for the management of gonorrhoea and genital chlamydia in genitourinary medicine clinics.

Authors:  N Low; J Welch; K Radcliffe
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

5.  Guidelines for managing raised blood pressure.

Authors:  R T Jackson; D L Sackett
Journal:  BMJ       Date:  1996-07-13

6.  Comparing hypertension guidelines. Audit in Mid-Glamorgan also shows major problems with management of hypertension.

Authors:  A J Burr
Journal:  BMJ       Date:  1996-11-09

7.  Comparing hypertension guidelines. Guidelines are based on evidence from trials, not normal practice.

Authors:  T J Scanlon; R Luben; P Lyle
Journal:  BMJ       Date:  1996-11-09

8.  Comparing hypertension guidelines. Technical difficulties may have affected study's results.

Authors:  S Barton; M Cranney; T Walley
Journal:  BMJ       Date:  1996-11-09

9.  Comparing hypertension guidelines. Cost effectiveness analyses have been carried out in Sweden.

Authors:  L H Lindholm; L Werkö
Journal:  BMJ       Date:  1996-11-09

10.  Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: a cross-sectional study of 1,032 medical inpatients.

Authors:  José Labarère; Jean-Luc Bosson; Jean-François Bergmann; Nathalie Thilly
Journal:  J Gen Intern Med       Date:  2004-08       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.